Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2018-11-01
2019-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Results:
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Dual Task Exercise Training in Children With Cerebral Palsy
NCT05999617
The Effect Of Somatosensory Perceptıon And Proprıoceptıon On Upper Extremıty Functıonal Skılls
NCT05213715
Motor Imagery and Functional Performance in Diplegic Cerebral Palsy
NCT07287215
The Relationship Between Lower Extremity Selective Motor Control and Gait in Children With Cerebral Palsy
NCT05749809
Effect of Upper Extremity Functional Skills on Quality of Life and Participation of the Children With Cerebral Palsy
NCT05194319
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Single: Walking without task at a self-selected speed
* Cognitive Task (CT): Walking while counting down rhythmically from 20 in threes
* Motor Task (MT): Walking while carrying an empty box
* CT + MT: Walking while carrying an empty box and counting down rhythmically from 20 in threes
The task was explained to individuals by a physiotherapist. The individuals were not allowed to use orthosis during walking performance. Running was not accepted. 30 seconds were given to take a break between tasks. The physiotherapist followed the individuals along the track in case of any falling. If the child was not able to complete the track (falling or need to rest), the evaluation was accepted uncomplete and was excluded from the database.
The Kinovea-08.15 software program was used to assess all of the outputs (images and videos) from the camera
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with hemiparetic Cerebral palsy
15 children with CP, between 9-15 years old
2D Gait analysis
The gait with four different conditions (single gait, Cognitive Task, Motor Task and Cognitive Task\&Motor Task) was evaluated by Kinovea video analysis method on a 10-meter course.
* Single: Walking without task at a self-selected speed
* Cognitive Task (CT): Walking while counting down rhythmically from 20 in threes
* Motor Task (MT): Walking while carrying an empty box
* CT + MT: Walking while carrying an empty box and counting down rhythmically from 20 in threes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2D Gait analysis
The gait with four different conditions (single gait, Cognitive Task, Motor Task and Cognitive Task\&Motor Task) was evaluated by Kinovea video analysis method on a 10-meter course.
* Single: Walking without task at a self-selected speed
* Cognitive Task (CT): Walking while counting down rhythmically from 20 in threes
* Motor Task (MT): Walking while carrying an empty box
* CT + MT: Walking while carrying an empty box and counting down rhythmically from 20 in threes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* being between 9-15 years of age, having a mental level as "normal" (in terms of compliance with the exercises)
* being in Gross Motor Function Classification System (GMFSC) Level I-II
* being in Manual Ability Classification System (MACS) Level I-II
* being in Communication Function Classification System (CFSS) Level I (communication method is speech).
Exclusion Criteria
* having severe vision impairment
* underwenting Botulinum Toxin (BOTOX) injection or surgery affecting lower extremities in the last 6 months.
9 Years
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medipol University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
mbudak
Miray Budak
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miray BUDAK, PhD
Role: STUDY_DIRECTOR
Medipol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Medipol University
Istanbul, Beykoz, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CogMo-CP2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.